Logo image of CXAI

CXAPP INC (CXAI) Stock Fundamental Analysis

NASDAQ:CXAI - Nasdaq - US23248B1098 - Common Stock - Currency: USD

1.1895  -0.2 (-14.42%)

Fundamental Rating

2

Overall CXAI gets a fundamental rating of 2 out of 10. We evaluated CXAI against 283 industry peers in the Software industry. Both the profitability and financial health of CXAI have multiple concerns. CXAI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CXAI had negative earnings in the past year.
CXAI had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CXAI reported negative net income in multiple years.
In the past 5 years CXAI always reported negative operating cash flow.
CXAI Yearly Net Income VS EBIT VS OCF VS FCFCXAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -61.03%, CXAI is doing worse than 84.81% of the companies in the same industry.
CXAI has a Return On Equity of -124.47%. This is in the lower half of the industry: CXAI underperforms 78.45% of its industry peers.
Industry RankSector Rank
ROA -61.03%
ROE -124.47%
ROIC N/A
ROA(3y)-2.25%
ROA(5y)-0.98%
ROE(3y)1279.74%
ROE(5y)768.23%
ROIC(3y)N/A
ROIC(5y)N/A
CXAI Yearly ROA, ROE, ROICCXAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K

1.3 Margins

CXAI has a better Gross Margin (82.01%) than 87.63% of its industry peers.
CXAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CXAI Yearly Profit, Operating, Gross MarginsCXAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1

2. Health

2.1 Basic Checks

CXAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CXAI has more shares outstanding
The debt/assets ratio for CXAI is higher compared to a year ago.
CXAI Yearly Shares OutstandingCXAI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
CXAI Yearly Total Debt VS Total AssetsCXAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -3.75, we must say that CXAI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CXAI (-3.75) is worse than 80.21% of its industry peers.
A Debt/Equity ratio of 0.33 indicates that CXAI is not too dependend on debt financing.
CXAI has a Debt to Equity ratio (0.33) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z -3.75
ROIC/WACCN/A
WACC10.32%
CXAI Yearly LT Debt VS Equity VS FCFCXAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

CXAI has a Current Ratio of 0.61. This is a bad value and indicates that CXAI is not financially healthy enough and could expect problems in meeting its short term obligations.
CXAI's Current ratio of 0.61 is on the low side compared to the rest of the industry. CXAI is outperformed by 88.69% of its industry peers.
A Quick Ratio of 0.61 indicates that CXAI may have some problems paying its short term obligations.
CXAI has a worse Quick ratio (0.61) than 88.34% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.61
CXAI Yearly Current Assets VS Current LiabilitesCXAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 63.01% over the past year.
CXAI shows a decrease in Revenue. In the last year, the revenue decreased by -3.08%.
EPS 1Y (TTM)63.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.51%
Revenue 1Y (TTM)-3.08%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.37%

3.2 Future

The Earnings Per Share is expected to grow by 26.36% on average over the next years. This is a very strong growth
CXAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 41.42% yearly.
EPS Next Y36.29%
EPS Next 2Y26.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20%
Revenue Next 2Y41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CXAI Yearly Revenue VS EstimatesCXAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 5M 10M 15M
CXAI Yearly EPS VS EstimatesCXAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CXAI. In the last year negative earnings were reported.
Also next year CXAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CXAI Price Earnings VS Forward Price EarningsCXAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CXAI Per share dataCXAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

CXAI's earnings are expected to grow with 26.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.36%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CXAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CXAPP INC

NASDAQ:CXAI (5/21/2025, 10:29:39 AM)

1.1895

-0.2 (-14.42%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-07 2025-04-07/amc
Earnings (Next)05-27 2025-05-27
Inst Owners6.66%
Inst Owner Change17.05%
Ins Owners19.09%
Ins Owner Change0%
Market Cap23.56M
Analysts82.86
Price Target4.08 (243%)
Short Float %7.56%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.29%
Min EPS beat(2)-30.72%
Max EPS beat(2)10.13%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.63%
Min Revenue beat(2)-18.58%
Max Revenue beat(2)3.32%
Revenue beat(4)1
Avg Revenue beat(4)-10.39%
Min Revenue beat(4)-22.51%
Max Revenue beat(4)3.32%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-36.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-40%
Revenue NY rev (3m)-40%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.3
P/FCF N/A
P/OCF N/A
P/B 1.51
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.23
EYN/A
EPS(NY)-0.81
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0.36
BVpS0.79
TBVpS-0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -61.03%
ROE -124.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.01%
FCFM N/A
ROA(3y)-2.25%
ROA(5y)-0.98%
ROE(3y)1279.74%
ROE(5y)768.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.07%
Cap/Sales 0.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.61
Altman-Z -3.75
F-Score4
WACC10.32%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.51%
EPS Next Y36.29%
EPS Next 2Y26.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.08%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.37%
Revenue Next Year20%
Revenue Next 2Y41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.1%
OCF growth 3YN/A
OCF growth 5YN/A